Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · IEX Real-Time Price · USD
3.550
-0.070 (-1.93%)
At close: May 31, 2024, 4:00 PM
3.710
+0.160 (4.51%)
After-hours: May 31, 2024, 7:48 PM EDT
Eton Pharmaceuticals Revenue
Eton Pharmaceuticals had revenue of $35.30M in the twelve months ending March 31, 2024, with 35.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.97M with 50.19% year-over-year growth. In the year 2023, Eton Pharmaceuticals had annual revenue of $32.64M with 42.60% growth.
Revenue (ttm)
$35.30M
Revenue Growth
+35.69%
P/S Ratio
2.58
Revenue / Employee
$1,176,800
Employees
30
Market Cap
91.20M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 32.64M | 9.75M | 42.60% |
Dec 31, 2022 | 22.89M | -441.00K | -1.89% |
Dec 31, 2021 | 23.33M | 23.29M | 59,725.64% |
Dec 31, 2020 | 39.00K | -920.00K | -95.93% |
Dec 31, 2019 | 959.00K | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Aurora Cannabis | 200.73M |
Xtant Medical Holdings | 101.23M |
SHL Telemedicine | 57.08M |
KORU Medical Systems | 29.32M |
Elutia | 28.99M |
ProPhase Labs | 28.72M |
ETON News
- 24 days ago - Eton Pharmaceuticals Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference - GlobeNewsWire
- 4 weeks ago - Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution) - GlobeNewsWire
- 4 weeks ago - Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 - GlobeNewsWire
- 2 months ago - Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE - Accesswire
- 2 months ago - Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 - GlobeNewsWire